Daiwa Securities Group
OCUL icon

Daiwa Securities Group’s Ocular Therapeutix OCUL Stock Holding History

Daiwa Securities Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-710
Closed -$9K – 1362
2025
Q4 		$9K Buy
710
+117
+20% +$1.42K ﹤0.01% 1194
2025
Q3 		$7K Hold
593
– – ﹤0.01% 1184
2025
Q2 		$6K Hold
593
– – ﹤0.01% 1150
2025
Q1 		$4K Hold
593
– – ﹤0.01% 1152
2024
Q4 		$5K Hold
593
– – ﹤0.01% 1165
2024
Q3 		$5K Buy
593
+186
+46% +$1.53K ﹤0.01% 1169
2024
Q2 		$3K Hold
407
– – ﹤0.01% 1233
2024
Q1 		$4K Buy
407
+145
+55% +$1.03K ﹤0.01% 1223
2023
Q4 		$1K Hold
262
– – ﹤0.01% 1305
2023
Q3 		$1K Hold
262
– – ﹤0.01% 1267
2023
Q2 		$1K Hold
262
– – ﹤0.01% 1288
2023
Q1 		$1K Hold
262
– – ﹤0.01% 1269
2022
Q4 		$1K Hold
262
– – ﹤0.01% 1283
2022
Q3 		$1K Hold
262
– – ﹤0.01% 1303
2022
Q2 		$1K Hold
262
– – ﹤0.01% 1306
2022
Q1 		$1K Hold
262
– – ﹤0.01% 1320
2021
Q4 		$2K Hold
262
– – ﹤0.01% 1292
2021
Q3 		$3K Buy
262
+128
+96% +$1.44K ﹤0.01% 1218
2021
Q2 		$2K Hold
134
– – ﹤0.01% 1147
2021
Q1 		$2K Hold
134
– – ﹤0.01% 1150
2020
Q4 		$3K Buy
+134
New +$1.99K ﹤0.01% 1093
2019
Q4 		– Sell
-268
Closed -$1K – 1234
2019
Q3 		$1K Hold
268
– – ﹤0.01% 1157
2019
Q2 		$1K Hold
268
– – ﹤0.01% 1184
2019
Q1 		$1K Buy
+268
New +$1.08K ﹤0.01% 1166

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Daiwa Securities Group's OCUL Position: Q1 2026 in Review

Daiwa Securities Group sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 710 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in OCUL in Q1 2019 and held it in 24 quarters. The position peaked at $9K in Q4 2025. 271 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Daiwa Securities Group reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 710 Ocular Therapeutix shares in Q1 2026, an estimated $9K.
  • Daiwa Securities Group first reported a position in Ocular Therapeutix in Q1 2019 and held it in 24 quarters.
  • Daiwa Securities Group's Ocular Therapeutix position peaked at $9K in Q4 2025.
  • 271 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.